News
Prescribing of drugs between 2021 and 2023 shifted dramatically for both type 2 diabetes and weight loss for people with ...
With age comes wisdom. But you know what else can come with age? Weight gain. Losing weight can also be harder as you grow ...
Service GLP-1 Medication Platform Offering Affordable Access to Semaglutide, Tirzepatide, and Phentermine with 24/7 Coaching, ...
Researchers at the Pennington Biomedical Research Center conducted a first-of-its-kind study to provide insights into the mechanisms of action of tirzepatide—a drug known as Zepbound—on weight loss ...
Jaime Almandoz, MD, MBA, of UT Southwestern Medical Center, speaks on results of a study that investigated tirzepatide uptake ...
3d
GlobalData on MSNEli Lilly sues Mochi Health and others for ‘deceptive’ tirzepatide marketingEli Lilly has filed a lawsuit against four telehealth platforms selling compounded versions of its blockbuster metabolic ...
In December 2024, the FDA affirmed that the shortage of tirzepatide, marketed as Zepbound for weight loss, had ended, ...
Tirzepatide linked to more GI issues than semaglutide in new study on weight-loss drugs without diabetes. Read more!
Eli Lilly said on Wednesday it had sued four compounders for selling unapproved products containing tirzepatide, after a U.S.
Eli Lilly ( NYSE: LLY) has filed lawsuits against four telehealth platforms that the pharma giant alleges are selling ...
Adults with overweight or obesity plus prediabetes maintain most of their weight loss with tirzepatide at more than 3 years, ...
The drug company Eli Lilly is suing four telehealth companies for allegedly selling copies made by compounding pharmacies of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results